subset nsaids lower amyloidogenic beta independently cyclooxygenase activity 
epidemiological studies documented reduced prevalence alzheimers disease among users nonsteroidal anti-inflammatory drugs nsaids- proposed nsaids exert beneficial effects part reducing neurotoxic inflammatory responses brain although mechanism proved report nsaids ibuprofen indomethacin sulindac sulphide preferentially decrease highly amyloidogenic beta peptide residue isoform amyloid-beta peptide produced variety cultured cells much % effect seen nsaids seems mediated inhibition cyclooxygenase cox activity principal pharmacological target nsaids furthermore short-term administration ibuprofen mice produce mutant beta amyloid precursor protein app lowered brain levels beta cultured cells decrease beta secretion accompanied increase beta - isoform indicating nsaids subtly alter gamma secretase activity without significantly perturbing app processing pathways notch cleavage findings suggest nsaids directly affect amyloid pathology brain reducing beta peptide levels independently cox activity beta lowering activity optimized selectively target pathogenic beta species 
